US Stock MarketDetailed Quotes

PTGX Protagonist Therapeutics

Watchlist
  • 25.790
  • -0.270-1.04%
Close May 7 16:00 ET
  • 25.790
  • 0.0000.00%
Post 16:59 ET
1.51BMarket Cap-18553P/E (TTM)

About Protagonist Therapeutics Company

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943. The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.

Company Profile

SymbolPTGX
Company NameProtagonist Therapeutics
Listing DateAug 11, 2016
Issue Price12.00
Founded2006
CEODr. Dinesh V. Patel, PhD
MarketNASDAQ
Employees112
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address7707 Gateway Boulevard,Suite 140
CityNewark
ProvinceCalifornia
CountryUnited States of America
Zip Code94560-1160
Phone1-510-474-0170
Websitehttp://www.protagonist-inc.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Dinesh V. Patel, PhD
  • Director, President and Chief Executive Officer
  • 7.07M
  • Asif Ali
  • Executive Vice President, Principal Accounting Officer and Chief Financial Officer
  • 1.40M
  • Dr. Arturo Molina, M.D.
  • Chief Medical Officer
  • --
  • Dr. Suneel Gupta, PhD
  • Chief Development Officer
  • 2.22M
  • Dr. Harold E. Selick, PhD
  • Chairman of the Board
  • 395.27K
  • Dr. Lewis T. Willia M.D.,PhD
  • Independent Director
  • 351.52K
  • Sarah A. O’Dowd
  • Independent Director
  • 341.52K
  • William D. Waddill
  • Independent Director
  • 364.02K
  • Daniel N. Swisher,Jr
  • Independent Director
  • 538.16K
  • Bryan Giraudo
  • Independent Director
  • 356.52K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg